We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Technology Offers Identification, Genotyping, and Characterization of Emerging Organisms

By LabMedica International staff writers
Posted on 22 Apr 2010
A program with public health applications includes epidemiologic surveillance, monitoring of pandemic diseases, and identification of emerging or previously unknown agents.

The Plex-ID system employs a combination of molecular technologies, including polymerase chain reaction (PCR) for gene amplification and mass spectrometry analysis to characterize rapidly known and unknown organisms. More...
It is designed to address a significant unmet need by providing test results in six to seven hours instead of three or more days as required with current laboratory methods.

Plex-ID, a product of Abbott (Abbott Park, IL, USA), can identify a broad range of bacteria, viruses, fungi, and certain parasites, and provide information about drug resistance, virulence, and strain type. It has the potential to be a powerful and versatile tool for public health laboratories, according to David N. Sundwall, Ph.D., executive director, Utah Department of Health (UDH; Salt Lake City, UT, USA).

"Plex-ID addresses the complex challenges of microbial identification by detecting and characterizing both known and previously unknown organisms found in a variety of specimens," Dr. Sundwall said. "The high-throughput technology offers our laboratory rapid detection and correct identification of a broad range of pathogens."

Dr. Sundwall added that for disease surveillance, the Plex-ID technology would enable public health officials to track emergent strains as they evolve, mutate, and possibly become more dangerous.

Abbott announced that the Utah Department of Health is one of five sites in the United States to participate in Abbott's new Plex-ID Biopreparedness Evaluation Program (BPEP), which involves Abbott, the Association of Public Health Laboratories (APHL; Silver Spring, MD, USA) and five state public health labs. The announcement was made at a ribbon-cutting ceremony for UDH's new multipurpose, state-of the-art Unified State Lab (USL; Taylorsville, UT, USA), a 7525 m2 facility that houses a variety of public-health laboratories.

In addition to Utah, the evaluation program will be conducted at state public health laboratories in Oklahoma, Minnesota, New York, and Virginia. In 2009, Plex-ID was recognized by both the Scientist and the Wall Street Journal as a top scientific innovation of the year.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture, and marketing of medical products, diagnostics, and pharmaceutics.

Related Links:
Abbott
Utah Department of Health
Association of Public Health Laboratories
Unified State Lab


New
Gold Member
Hematology Analyzer
Medonic M32B
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Rapid Test Reader
DIA5000
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.